Search
5 days ago
Seattle and San Carlos, CA based Nautilus Biotechnology is developing a platform that aims to revolutionize how researchers are able to see the proteome. CEO Sujal Patel tells us how it will work
He describes the shortcomings of high affinity assays and mass spectometry, and how the Nautilus system will be different. Plus, use...